Customized Proteomics Solutions for Expedited Drug Discovery

Proteomics studies can be applied to advance early- to mid-stage drug discovery and development efforts. From total proteome, to post-translational modification analysis, to signaling pathway elucidation, proteomics studies can increase effectiveness and decrease timelines for target/biomarker identification and understanding of mechanism of action and off-target effects.

Explore the full suite of customized proteomics solutions on the Proteomics Services page.

Presenter: Matthew P. Stokes, PhD, Associate Director, Proteomics and Services, Cell Signaling Technology.

This webinar is geared toward scientists focused on therapeutic discovery and development:

Your work in the discovery pipeline:

• Target Identification
• Screening
• Hit-to-lead

Challenges you may be facing:

• Time pressure to move candidates to the next stage
• Having to educate yourself on areas of biology you haven't (yet) studied
• Having sufficient data to make go/no-go decisions
• Ensuring the data you depend on is reproducible

What you'll learn:

• How to observe and interpret the behavior of thousands of proteins in your sample when treated with your compound
• The role of post-translational modifications in therapeutic response
• How proteomics data can help guide experimental design, assay development and biomarker discovery
• How to leverage external expertise in your discovery and development activity